ALEMBIC Fact Sheet, ALEMBIC Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC Fact Sheet   (ALMC)


One Stock Crorepati: Today is Your LAST Chance to Grab this Opportunity


Here is the latest financial fact sheet of ALEMBIC. For more details, see the ALEMBIC quarterly results and ALEMBIC share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC Price History

Price Rs 68.7
Mkt Cap Rs m 17,641
Vol '000 90.4
P/E X 20.5
P/CF X 99.2
EPS (TTM) Rs 3.4
1 Day % 9.9
No. of shares m 256.78
1 Week % 15.5
1 Month % -0.8
1 Year % -45.6
52 week H/L Rs 139.4/56.5
As on Jul 4, 2022 03:31:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ALEMBIC EQUITY SHARE DATA
High Rs46726265123 
Low Rs3234362532 
Sales per share (Unadj.) Rs5.34.64.82.92.9 
Earnings per share (Unadj.) Rs1.01.61.63.60.5 
Diluted earnings per shareRs1.11.61.63.60.5 
Cash flow per share (Unadj.) Rs1.21.71.73.70.7 
Dividends per share (Unadj.) Rs0.200.200.200.600.20 
Adj. dividends per shareRs0.210.210.200.600.20 
Avg Dividend yield %0.50.40.41.30.3 
Book value per share (Unadj.) Rs34.140.747.155.289.5 
Adj. book value per shareRs35.542.347.155.289.5 
Shares outstanding (eoy) m267.03267.03256.78256.78256.78 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x7.411.410.215.627.0 
Avg P/E ratio x38.333.830.712.4143.5 
P/CF ratio (eoy) x32.331.028.812.0111.7 
Price / Book Value ratio x1.21.31.00.80.9 
Dividend payout %19.412.812.516.637.1 
Avg Mkt Cap Rs m10,52114,13312,60811,52319,868 
No. of employees `000NANANANANA 
Total wages/salary Rs m228196205208226 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
ALEMBIC INCOME DATA
Net Sales Rs m1,4131,2351,238739735 
Other income Rs m310370295935109 
Total revenues Rs m1,7231,6061,5331,675844 
Gross profit Rs m911118131104 
Depreciation Rs m5138263239 
Interest Rs m22234 
Profit before tax Rs m266442447932170 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-92436132 
Profit after tax Rs m275418411930138 
Gross profit margin %0.69.014.64.214.2 
Effective tax rate %-3.25.48.00.118.8 
Net profit margin %19.533.833.2125.818.8 
ALEMBIC BALANCE SHEET DATA
Current assets Rs m1,9131,8679881,6281,021 
Current liabilities Rs m683591488458594 
Net working cap to sales %87.0103.340.4158.358.1 
Current ratio x2.83.22.03.61.7 
Inventory Days Days1,9582,6982,9525,59610,191 
Debtors Days Days558747398444686 
Net fixed assets Rs m8,0119,72311,67113,07923,069 
Share capital Rs m534534514514514 
"Free" reserves Rs m8,58010,32411,57213,66722,457 
Net worth Rs m9,11410,85812,08514,18022,970 
Long term debt Rs m00000 
Total assets Rs m9,92411,59012,65814,70724,090 
Interest coverage x169.6262.4207.8324.548.1 
Debt to equity ratio x00000 
Sales to assets ratio x0.10.10.10.10 
Return on assets %2.83.63.36.30.6 
Return on equity %3.03.83.46.60.6 
Return on capital %2.94.13.76.60.8 
Exports to sales %0.71.62.52.21.5 
Imports to sales %25.221.331.218.66.1 
Exports (fob) Rs m1019301611 
Imports (cif) Rs m35626338613845 
Fx inflow Rs m1019301611 
Fx outflow Rs m35726438713845 
Net fx Rs m-346-244-357-121-34 
ALEMBIC CASH FLOW
From Operations Rs m 516 236 215 65 -22 
From Investments Rs m -467 -224 717 567 -347 
From Financial Activity Rs m -50 -27 -920 -64 -154 
Net Cashflow Rs m -0 -15 12 569 -523 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 70.9%
Institution 5.8%
Non-Institution 23.3%
Total 100.0%
Free Float 29.1%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Alembic Road, Vadodara - 390003
E-mail alembic.investors@alembic.co.in Web www.alembiclimited.com
Tel 0265-2280550 / 2280880 Fax 0265-2282506
Sector PHARMACEUTICALS Group Alembic Group
Tr Agent Link Intime India Pvt Ltd., B-102 & B103 Shangrila Complex First Floor, Opp: HDFC Bank Near Radhakrishna Char Rasta, Akota
Auditor K. S. Aiyar & Co.
CHM: Chirayu Amin COMP SEC: Drigesh Mittal YEAR OF INC: 1907 BSE CODE: 506235 FV (Rs): 2 DIV YIELD (%): 0.3

Read: ALEMBIC 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare ALEMBIC With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    


Yellow Ad

Advertisement

Last Day to Access 'One Stock Crorepati' Opportunity

As you know, recently we went LIVE with our One Stock Crorepati MEGA Summit...

Around 10,000 readers like you had registered to attend this summit.

At the summit, they learned Richa Agarwal's secret blueprint of identifying potential 'crorepati' stocks.

Plus, they also discovered the details of one stock with crorepati potential...

If you missed this summit for some reason, then you can still get all the details by watching this special replay of the summit.

Learn more



Today's Market

Sensex Ends 327 Points Higher as FMCG Stocks Rally; HUL, Britannia & ITC Top Gainers(Closing)

After opening the day on a choppy note, Indian share markets rallied as the session progressed and ended higher.

Views on news

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

5 Consistent Compounding Stocks Available at Discount. Time to Buy? (Views On News)

Jun 22, 2022

The good side of a market correction? Investors get consistent compounding stocks at a discount.

Wait! Don't Buy the Smallcap 'Dip' Just Yet (Profit Hunter)

Jun 20, 2022

Why this may not be the best time to buy smallcaps.

Looking for Value Stocks Amid Volatile Times? Consider These 5 Stocks (Views On News)

Jun 20, 2022

These value stocks have the potential to deliver good returns in the long run. Watch out for them.

Why Crude Oil Price is Falling (Views On News)

Jun 25, 2022

Global markets have become volatile, sending chills through the crude oil market.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC

ALEMBIC - TEVA PHARMA COMPARISON

COMPARE ALEMBIC WITH

MARKET STATS